Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision updates from v3.0.1 to v3.0.2, and the 'Back to Top' element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:53:24.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T16:51:40.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to include a specific facility name and location in Goyang-si, Gyeonggi-do, South Korea, while removing several references to previous location terms and specific medical topics related to cancer treatment.
    Difference
    3%
    Check dated 2025-08-31T12:03:33.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:34:40.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:28:43.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T19:00:12.000Z thumbnail image

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.